Next Article in Journal
GMP Manufacturing and Characterization of the HIV Booster Immunogen HxB2.WT.Core-C4b for Germline Targeting Vaccine Strategies
Previous Article in Journal
Recent Advancements in Non-Invasive Vaccination Strategies
Previous Article in Special Issue
A QS21 + CpG-Adjuvanted Trivalent HSV-2 Vaccine and Trivalent HSV-2 mRNA Vaccine Induce a Strong Immune Response, Protect Against HSV-2 Infection, and Cross-Protect Against HSV-1 Infection in Mice
 
 
Review

Article Versions Notes

Vaccines 2025, 13(9), 979; https://doi.org/10.3390/vaccines13090979
Action Date Notes Link
article xml file uploaded 17 September 2025 11:01 CEST Original file -
article xml uploaded. 17 September 2025 11:01 CEST Update https://www.mdpi.com/2076-393X/13/9/979/xml
article pdf uploaded. 17 September 2025 11:01 CEST Version of Record https://www.mdpi.com/2076-393X/13/9/979/pdf
article html file updated 17 September 2025 11:02 CEST Original file https://www.mdpi.com/2076-393X/13/9/979/html
Back to TopTop